The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 21, 2020
Filed:
Jul. 07, 2016
Applicant:
Sandia Corporation, Albuquerque, NM (US);
Inventors:
Oscar A. Negrete, Livermore, CA (US);
Brooke Nicole Harmon, Livermore, CA (US);
Assignee:
National Technology & Engineering Solutions of Sandia, LLC, Albuquerque, NM (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/40 (2006.01); A61K 31/235 (2006.01); A61K 31/35 (2006.01); A61K 31/44 (2006.01); A61K 31/47 (2006.01); A61K 31/519 (2006.01); A61K 31/135 (2006.01); A61K 31/18 (2006.01); A61K 31/42 (2006.01); A61K 31/425 (2006.01); A61K 38/17 (2006.01); A61K 31/407 (2006.01); A61K 31/475 (2006.01); A61K 31/4439 (2006.01); A61K 31/136 (2006.01); C12Q 1/6883 (2018.01);
U.S. Cl.
CPC ...
A61K 38/1709 (2013.01); A61K 31/136 (2013.01); A61K 31/407 (2013.01); A61K 31/4439 (2013.01); A61K 31/475 (2013.01); C12Q 1/6883 (2013.01); C12Q 2600/178 (2013.01);
Abstract
The present invention relates to methods for treating a disease, in which the disease arises from dysregulation of the Wnt signaling pathway. In some instances, the disease can be treated by administering a Wnt pathway inhibitory compound. In other instances, the method optionally includes conducting a genome-wide screening to determine one or more genes resulting in a reduced disease state and then identifying the gene(s) as being involved in the Wnt signaling pathway.